Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1891747

Cover Image

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1891747

Postpartum Hemorrhage (PPH) Treatment Devices

PUBLISHED:
PAGES: 207 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Postpartum Hemorrhage (PPH) Treatment Devices Market to Reach US$1.1 Billion by 2030

The global market for Postpartum Hemorrhage (PPH) Treatment Devices estimated at US$851.9 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$521.7 Million by the end of the analysis period. Growth in the Non-Pneumatic Anti-Shock Garment (NASG) segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$289.6 Million While China is Forecast to Grow at 6.1% CAGR

The Postpartum Hemorrhage (PPH) Treatment Devices market in the U.S. is estimated at US$289.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$146.8 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Postpartum Hemorrhage (PPH) Treatment Devices Market - Key Trends & Drivers Summarized

Postpartum hemorrhage (PPH), also termed as postpartum bleeding, is a medical complication characterized by loss of over 500ml or 1,000ml of blood in women within the initial 24 hours after childbirth. Prevalent across both developed and developing countries, the condition is linked with a large number of mortalities. Uterine massage is considered as the first line treatment for ensuring contraction of the uterus and reducing bleeding. On the other hand, various medical professionals rely on non-pneumatic anti-shock garment (NASG) for delivery outside a healthcare setting. The approach improves shock in the pregnant women with obstetrical bleeding, providing the rime to reach hospital. Uterine balloon tamponades are also used for treating PPH among patients who are unresponsive to primary interventions and uterotonics. Uterine balloon tamponade hold potential to considerable improve the condition. In addition, inflating the Sengstaken-Blakemore tube in uterus can treat atonic PPH in majority of cases.

Technological advancements have led to the development of more effective and user-friendly devices, which are being increasingly adopted in both developed and developing countries. Uterine balloon tamponades, such as the Bakri balloon, have become standard in many medical settings due to their effectiveness and ease of use. These devices can be rapidly deployed and are minimally invasive, making them suitable for use in diverse healthcare environments, including low-resource settings. Electrosurgical devices and hemostatic agents have also evolved, offering precise and effective means to control bleeding. Non-pneumatic anti-shock garments, which apply circumferential pressure to reduce blood loss and maintain vital organ perfusion, are increasingly used in emergency settings, particularly in developing countries. The integration of these devices with digital monitoring systems allows for real-time assessment and management of blood loss, improving patient outcomes.

The growth in the PPH treatment devices market is driven by several factors, including rising global incidence of PPH and the growing awareness about maternal health. Rising complications concerning pregnancy, namely large-sized babies, multiple pregnancies, and inverted uterus are also fueling market growth. Further, increase in other risk factors of PPH, like traumatic uterine and uterine atony, an increase in pregnant women with anemia conditions, and rising awareness concerning PPH risks boost the market growth of postpartum hemorrhage devices. The expanding healthcare infrastructure, especially in emerging economies, has facilitated greater access to these advanced treatment options. Moreover, government initiatives and funding aimed at reducing maternal mortality rates have bolstered market growth. The demand for minimally invasive and easy-to-use devices that can be employed in a variety of healthcare settings, from tertiary care hospitals to rural clinics, has also spurred innovation in this field. These factors collectively ensure the robust expansion of the market, addressing a critical need in maternal healthcare.

SCOPE OF STUDY:

The report analyzes the Postpartum Hemorrhage (PPH) Treatment Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG), Uniject Prefilled Injection System)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Brazil; Rest of Latin America; Middle East; Africa.

Select Competitors (Total 26 Featured) -

  • 3RD Stone Design, Inc.
  • Cook Medical LLC
  • Laborie Medical Technologies Corporation
  • Organon & Co.
  • Sinapi Biomedical
  • Utah Medical Products, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP15984

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Postpartum Haemorrhage - The Leading Cause of Maternal Death Globally
    • PPH: Management using PPH Treatment Devices
    • Global Postpartum Haemorrhage (PPH) Treatment Devices Market by Geographic Region: Annual Sales in Million Units for the Years 2023 through 2030
    • Global Postpartum Haemorrhage (PPH) Treatment Devices Market by Product Segment: Annual Sales in Thousand Units for the Years 2022 through 2030
    • Economic Frontiers: Trends, Trials & Transformations
    • In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
    • All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
    • With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Competitive Landscape
    • Postpartum Hemorrhage (PPH) Treatment Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Global Market Prospects and Outlook
    • Global Postpartum Hemorrhage Devices Market Sets Eyes on Pulsating Growth Ahead
    • Uterine Balloon Tamponades Lead the Global PPH Treatment Devices Market
    • US and Europe Account for Major Share of the Market
    • Developing and Developed Countries Investing More in Healthcare Industry
    • Restraining Factors for Market Growth
    • Recent Market Activity
    • Influencer/Product/Technology Insights
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Robust Scope for Device Innovations to Shoulder Burden of Mortality Reduction Goals
    • PPH Device R&D Pipeline: Breakdown of PPH Devices by Development Status
    • Current PPH Devices Ecosystem by Archetype & Clinical Use Status
    • Existing & Promising Postpartum Hemorrhage Devices
    • Balloons Command while New Options Emerge
    • Uterine balloon Tamponade PPH Devices by Archetype & Clinical Use Status
    • Widespread Use of Repurposed & Improvised PPH Devices
    • The Way Forward
    • Novel Techniques for Accurate, Timely Detection & Efficient Management of PPH
    • Timely Hemorrhage Detection
    • Fixed-Ratio Transfusion
    • Viscoelastic Hemostatic Assays
    • Approaches to Reduce Disparate Outcomes
    • Obstetricians Develop Novel Intrauterine PPH Device to Control Postpartum Bleeding
    • Increase in Birth Rate Offers Opportunities for Postpartum Hemorrhage Market
    • Global New Births (in Millions) per Annum by Geographic Region
    • Birth Statistics Across the World
    • Rise in Pregnancy Complications Drives Market Growth
    • Prevalence of Anaemia in Pregnant Women Bolsters Demand
    • The Millennials Reaching Child-Bearing Age Drive Healthy Market Growth
    • Rising Working Women Population Increases the Risk of PPH
    • Top 10 Countries Worldwide with the Highest Proportion of Working Women in the Nation's Women Population
    • Rising Obesity Incidence Spurs the Demand for PPH Treatment Devices
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2023 and 2030P
    • Non-Pneumatic Anti-Shock Garment Witnesses Increased Demand
    • Leading Players and Market Share
    • Reduction in Maternal Mortality Rates due to Obstetric Haemorrhage from the Use of NASG in Select Countries
    • Supply
    • Challenges and Issues
    • Uterotonics: The Lifeblood of the Bundle Approach to Manage Postpartum Hemorrhage
    • More Focus on Uterine Atony & Uterotonics
    • Uterotonics Move Forward with New Advances to Prevent Postpartum Hemorrhage
    • Device Innovations to Control PPH to Drive Market Growth
    • PATH and Sinapi Biomedical Introduce Ellavi for Combating Postpartum Haemorrhage
    • PPH Butterfly
    • Intrauterine Vacuum Device Plays a Crucial Role in Controlling Postpartum Hemorrhage Safely and Quickly
    • Tools to Detect and Treat Postpartum Hemorrhage Minimize Maternal Deaths
    • New Wearable Optical Device for Timely Detection of Postpartum Hemorrhage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Postpartum Hemorrhage (PPH) Treatment Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Uterine Balloon Tamponade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Uniject Prefilled Injection System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • JAPAN
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • CHINA
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • EUROPE
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • FRANCE
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • GERMANY
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • INDIA
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 80: Rest of Latin America Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Latin America 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 83: Middle East Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Middle East Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Middle East 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030
  • AFRICA
    • Postpartum Hemorrhage (PPH) Treatment Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 86: Africa Recent Past, Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Africa Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Africa 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!